XML 41 R29.htm IDEA: XBRL DOCUMENT
v3.25.3

Organization and Nature of Business (Details) - USD ($) |  |  |  |  |  |  |  | 1 Months Ended | 3 Months Ended | 9 Months Ended |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Sep. 26, 2025 | Sep. 24, 2025 | Aug. 21, 2025 | Aug. 13, 2025 | Apr. 20, 2023 | Aug. 10, 2022 | Aug. 03, 2021 | Sep. 30, 2025 | Aug. 31, 2025 | Sep. 30, 2025 | Mar. 31, 2025 | Sep. 30, 2024 | Sep. 30, 2025 | Sep. 30, 2024 | Dec. 31, 2024
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs |  |  |  |  |  |  |  |  |  | $ 1,343,379 | $ 13,676,667 | $ 4,237,397 |  |  |
Reduction in offer price, of income capacity |  |  |  |  |  |  |  | $ 1,250,007 |  |  |  |  |  |  |
Share unfunded exercise price |  |  | $ 0.001 |  |  |  |  |  |  |  |  |  |  |  |
Issuance costs |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,138,911 | $ 0 |
Accumulated deficit |  |  |  |  |  |  |  | $ (268,740,074) |  | $ (268,740,074) |  |  | $ (268,740,074) |  | $ (224,295,186)
Share Distribution Agrement, Three Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  |  |  |  |  |  |  | $ 4.27 |  | $ 4.27 |  |  | $ 4.27 |  |
Share Distribution Agreement, Nine Months Ended |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  |  |  |  |  |  |  | 4.27 |  | $ 4.27 |  |  | $ 4.27 |  |
Pre Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  |  | 3.949 |  |  |  |  |  |  |  |  |  |  |  |
Investor |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  |  | $ 3.95 |  |  |  |  |  |  |  |  |  |  |  |
IPO |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of common stock under at-the-market offering, net of issuance costs |  |  |  |  |  |  | $ 120,318,750 |  |  |  |  |  |  |  |
Offering costs |  |  |  |  |  |  | $ 2,124,317 |  |  |  |  |  |  |  |
At-the-market offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) |  |  |  |  |  |  |  |  |  | 327,355 |  | 1,318,752 | 5,164,159 | 1,318,752 |
Proceeds from issuance of common stock under at-the-market offering, net of issuance costs |  |  |  |  |  |  |  |  |  | $ 1,300,000 |  | $ 4,200,000 | $ 15,020,046 | $ 4,237,397 |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs |  |  |  | $ 100,000,000 |  | $ 50,000,000 |  |  |  | $ 1,400,000 |  | $ 4,500,000 | $ 15,600,000 | $ 4,500,000 |
Sale of stock (in dollars per share) |  |  |  |  |  |  |  | 3.03 |  | $ 3.03 |  | $ 3.38 | $ 3.03 | $ 3.38 |
Aggregate gross sales proceeds |  |  |  |  |  |  |  |  |  |  |  |  | $ 98,749,993 |  |
Underwriting Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  |  |  |  | $ 11.00 |  |  |  |  |  |  |  |  |  |
Shares sold (in shares) |  |  |  |  | 2,727,273 |  |  |  |  |  |  |  |  |  |
Proceeds from company offering |  |  |  |  | $ 28,200,003 |  |  |  |  |  |  |  |  |  |
Sale of stock, proceeds before deducting offering costs payable |  |  |  |  | $ 203,768 |  |  |  |  |  |  |  |  |  |
Purchase Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) |  |  | 2,848,096 |  |  |  |  |  |  |  |  |  |  |  |
Class of warrant or right, exercise price of warrants or rights |  |  | $ 5.50 |  |  |  |  | 5.50 |  | 5.50 |  |  | $ 5.50 |  |
Issuance costs |  |  |  |  |  |  |  |  |  |  |  |  | $ 3,700,000 |  |
Private Placement |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Proceeds from issuance of common stock under at-the-market offering, net of issuance costs |  |  |  |  |  |  |  |  | $ 23,400,000 |  |  |  |  |  |
Class of warrant or right, exercise price of warrants or rights |  |  |  |  |  |  |  | 5.50 |  | $ 5.50 |  |  | $ 5.50 |  |
Issuance costs |  |  |  |  |  |  |  |  |  |  |  |  | $ 1,600,000 |  |
Private Placement | Aventis Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs |  |  |  |  |  |  |  |  |  | $ 23,300,000 |  |  |  |  |
Issuance costs |  |  |  |  |  |  |  |  |  | $ 200,000 |  |  |  |  |
Private Placement | Sanofi Private Placement | Aventis Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs |  | $ 23,300,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance costs |  | $ 200,000 |  |  |  |  |  |  |  |  |  |  |  |  |
Pre Funded Warrants |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) |  |  | 1,077,764 |  |  |  |  |  |  |  |  |  |  |  |
Class of warrant or right, exercise price of warrants or rights |  |  |  |  |  |  |  | 0.001 |  | $ 0.001 |  |  | $ 0.001 |  |
Class A Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) | 18,959,914 |  | 5,251,349 |  |  |  | 1,125,000 |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs | $ 164,100,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) | $ 9.23 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value per share (in dollars per share) |  |  |  |  |  |  |  | $ 0.001 |  | $ 0.001 |  |  | $ 0.001 |  | $ 0.001
Issuance costs | $ 400,000 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Class A Common Stock | IPO |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) |  |  |  |  |  |  | 8,625,000 |  |  |  |  |  |  |  |
Class A Common Stock | At-the-market offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Shares sold (in shares) |  |  |  |  |  |  |  |  |  | 0 |  | 0 | 0 | 0 |
Common stock, par value per share (in dollars per share) |  |  |  |  |  | $ 0.001 |  |  |  |  |  |  |  |  |
Aggregate gross sales proceeds |  |  |  | $ 100,000,000 |  | $ 50,000,000 |  |  |  |  |  |  |  |  |
Class A Common Stock | Underwriting Offering |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Common stock, par value per share (in dollars per share) |  |  |  |  | $ 0.001 |  |  |  |  |  |  |  |  |  |
Class A Common Stock | Private Placement | Sanofi Private Placement | Aventis Inc. |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Sale of stock (in dollars per share) |  | $ 9.23 |  |  |  |  |  |  |  |  |  |  |  |  |
Common Stock |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Organization and Nature of Business |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of common stock upon public offering, net of commissions, underwriting discounts and issuance costs (in shares) |  | 2,708,559 |  |  |  |  |  |  |  |  |  |  |  |  |

X
- Definition Amount of maximum aggregate gross proceeds from equity offering. + References No definition available. + Details
Name: | imrx_MaximumAggregateGrossProceedsFromEquityOffering
Namespace Prefix: | imrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of offering costs payable by the Company. + References No definition available. + Details
Name: | imrx_OfferingCostPayable
Namespace Prefix: | imrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Sale Of Stock, Net Proceeds After Deducting Underwriting Discount And Commission + References No definition available. + Details
Name: | imrx_SaleOfStockNetProceedsAfterDeductingUnderwritingDiscountAndCommission
Namespace Prefix: | imrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Sale Of Stock, Proceeds Before Deducting Offering Costs Payable + References No definition available. + Details
Name: | imrx_SaleOfStockProceedsBeforeDeductingOfferingCostsPayable
Namespace Prefix: | imrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Share Unfunded Exercise Price + References No definition available. + Details
Name: | imrx_ShareUnfundedExercisePrice
Namespace Prefix: | imrx_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Stock Issued During Period, Value, Decrease Due To Reduced Offering Price + References No definition available. + Details
Name: | imrx_StockIssuedDuringPeriodValueDecreaseDueToReducedOfferingPrice
Namespace Prefix: | imrx_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15 + Details
Name: | us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The cash inflow from the additional capital contribution to the entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfCommonStock
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of accumulated undistributed earnings (deficit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(30)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 852 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 10 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (g)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(23)(a)(4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(17)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_RetainedEarningsAccumulatedDeficit
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of new stock issued during the period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(i)(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 4 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478009/946-205-45-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodValueNewIssues
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_SubsidiaryOrEquityMethodInvesteeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis=imrx_ShareDistributionAgreementThreeMonthsEndedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_DistributionsMadeToMemberOrLimitedPartnerByDistributionTypeAxis=imrx_ShareDistributionAgreementNineMonthsEndedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=imrx_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=us-gaap_InvestorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=imrx_AtMarketOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=imrx_UnderwritingOfferingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=imrx_PurchaseWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_CounterpartyNameAxis=imrx_AventisInc.Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=imrx_SanofiPrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=imrx_PreFundedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |